Pharmacological and non-pharmacological management of COPD; limitations and future prospects: a review of current literature.
Objective: This article aimed to summarize the pharmacological and non-pharmacological management of COPD and limitations and prospects of the currently available pharmacological therapies in the management of COPD. Background: COPD is a complex comorbid disease that irreversibly affects the pulmona...
| Publicado en: | Journal of Public Health: From Theory to Practice (2198-1833) Vol. 28; no. 4; pp. 357 - 367 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artículo |
| Publicado: |
Springer Nature
Aug2020
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=144520950&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 144520950 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 21981833 NENI jtl: Journal of Public Health: From Theory to Practice (2198-1833) issn: 21981833 maglogo: N pubinfo: dt: Aug2020 vid: 28 iid: 4 pid: 237 pub: Springer Nature artinfo: ui: 144520950 10.1007/s10389-019-01021-3 ppf: 357 ppct: 10 formats: tig: atl: Pharmacological and non-pharmacological management of COPD; limitations and future prospects: a review of current literature. aug: au: ur Rehman, Anees Hassali, Mohamed Azmi Ahmad Abbas, Sameen Ali, Irfhan Ali Bin Hyder Harun, Sabariah Noor Muneswarao, Jaya Hussain, Rabia affil: School of Pharmaceutical Sciences, University Sains Malaysia, 11800, Minden, Penang, Malaysia Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan Department of Pharmacy, Quaid e Azam University, Islamabad, Pakistan Respiratory Department, Hospital Pulau Pinang, Penang, Ministry of Health Malaysia, George Town, Malaysia Pharmacy Department, Hospital Kulim, Kedah, Ministry of Health Malaysia, Kulim, Malaysia su: Drugs Immunization Influenza vaccines Patient compliance Quality of life Obstructive lung disease treatment Adrenocortical hormones Antibiotics Bronchodilator agents Lung diseases Obstructive lung diseases Medical rehabilitation Oxygen therapy Pneumococcal vaccines Pneumonectomy Respiratory therapy equipment Smoking cessation Disease management Treatment effectiveness sug: subj: Drugs Immunization Influenza vaccines Patient compliance Quality of life Pharmaceutical and medicine manufacturing Drugs and Druggists' Sundries Merchant Wholesalers Pharmaceuticals and pharmacy supplies merchant wholesalers Medicinal and Botanical Manufacturing Surgical Appliance and Supplies Manufacturing Medical equipment and supplies manufacturing Electromedical and Electrotherapeutic Apparatus Manufacturing All Other Miscellaneous Ambulatory Health Care Services All other ambulatory health care services Obstructive lung disease treatment Adrenocortical hormones Antibiotics Bronchodilator agents Lung diseases Obstructive lung diseases Medical rehabilitation Oxygen therapy Pneumococcal vaccines Pneumonectomy Respiratory therapy equipment Smoking cessation Disease management Treatment effectiveness keyword: COPD Non-pharmacological management Pharmacological treatment Review COPD Non-pharmacological management Pharmacological treatment Review ab: Objective: This article aimed to summarize the pharmacological and non-pharmacological management of COPD and limitations and prospects of the currently available pharmacological therapies in the management of COPD. Background: COPD is a complex comorbid disease that irreversibly affects the pulmonary system and is considered the fifth leading cause of death worldwide. Currently, the diagnosis, assessment and management of COPD are difficult because of its complex syndrome involving numerous pulmonary and extra-pulmonary components. It is diagnosed based on the subjective and objective findings of a chronic cough, sputum production, dyspnoea, exercise intolerance and spirometry values. The GOLD report recommends bronchodilators as the first-line treatment agents in all stages of COPD severity, commonly combined with inhaled corticosteroids (ICS), methylxanthines and antibiotics, depending upon the condition and symptoms of patients. Non-pharmacological treatments of COPD include smoking cessation, influenza and pneumococcal vaccination, pulmonary rehabilitation, LTOT and surgical lung volume reduction. The efficacy of the therapy is directly related to the patients' inhaler use training and education. A new future in COPD medication is essential to ensure the optimal management of COPD. New alternative sources should be considered in the treatment of COPD. Conclusion: New approaches such as e-technology can play an essential role in improving compliance and adherence to therapy. New therapies with better and long-lasting effects and minimized side effects need to be discovered to improve the pharmacological management of COPD. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|